Literature DB >> 35841220

Seroprevalence of Borrelia IgG antibodies among individuals from Eastern Slovakia.

Andrea Houžvičková1, Erik Dorko1, Kvetoslava Rimárová1, Jana Diabelková1, Erik Drabiščák1.   

Abstract

OBJECTIVES: Lyme borreliosis is a tick-borne disease of increasing incidence and public concern. Our cross-sectional study was aimed at evaluating seroprevalence of Borrelia burgdorferi in a group of respondents from Eastern Slovakia.
METHODS: In total, 515 blood samples collected in 2013-2016 were analysed with NovaLisaTM, NovaTec - Borrelia IgG/IgM kit (Immunodiagnostica, Dietzenbach, Germany). Positive and equivocal IgG-antibody results were further examined with immunoblotting (LYMECHECK® OPTIMA IgG and IgM kits, BIOSYNEX, France). Data detected by serological methods were matched with those obtained from a questionnaire. Differences between groups by residence/seropositivity were tested by χ2 test. The effect of socio-demographic and risk factors on seropositivity of IgG antibodies was assessed using binary logistic regression.
RESULTS: IgG antibodies against Borrelia burgdorferi were detected in 67 cases (13.01%) and IgM antibodies in 40 cases (7.8%). Previous tick bite had been noted in 67.2% of these seropositive individuals. Higher seropositivity was observed in men and persons aged over 61 years. Rural residents had higher seropositivity (39%) than those living in urban (29%) areas. Very few of these seropositive persons reported prior symptoms.
CONCLUSION: The study reveals that IgG-seropositivity for Borrelia burgdorferi in Eastern Slovakia is predominant in men and occurs mainly in rural areas. The findings also suggest that exposure to Borrelia burgdorferi (with subsequent antibody response in serum) does occur, mostly without giving rise to clinical Lyme borreliosis.

Entities:  

Keywords:  Borrelia burgdorferi sensu lato; Lyme borreliosis; seroprevalence; seropositivity

Mesh:

Substances:

Year:  2022        PMID: 35841220     DOI: 10.21101/cejph.a6808

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.154


  14 in total

Review 1.  Epidemiology of Lyme disease.

Authors:  Paul S Mead
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 2.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

3.  Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009.

Authors:  Knut Eirik Eliassen; Dag Berild; Harald Reiso; Nils Grude; Karen Sofie Christophersen; Cecilie Finckenhagen; Morten Lindbæk
Journal:  Ticks Tick Borne Dis       Date:  2016-06-30       Impact factor: 3.744

4.  Seroprevalence of Lyme disease in southwest Asturias.

Authors:  Lucía Barreiro-Hurlé; Santiago Melón-García; Carolina Seco-Bernal; Carmen Muñoz-Turrillas; Mercedes Rodríguez-Pérez
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2019-09-02

5.  Lyme disease in Western Europe: an emerging problem? A systematic review.

Authors:  Olivia Vandekerckhove; Emmy De Buck; Eric Van Wijngaerden
Journal:  Acta Clin Belg       Date:  2019-11-18       Impact factor: 1.264

6.  The enzootic life-cycle of Borrelia burgdorferi (sensu lato) and tick-borne rickettsiae: an epidemiological study on wild-living small mammals and their ticks from Saxony, Germany.

Authors:  Anna Obiegala; Nina Król; Carolin Oltersdorf; Julian Nader; Martin Pfeffer
Journal:  Parasit Vectors       Date:  2017-03-13       Impact factor: 3.876

7.  The demographics and geographic distribution of laboratory-confirmed Lyme disease cases in England and Wales (2013-2016): an ecological study.

Authors:  John S P Tulloch; Amanda E Semper; Tim J G Brooks; Katherine Russell; Kate D Halsby; Robert M Christley; Alan D Radford; Roberto Vivancos; Jenny C Warner
Journal:  BMJ Open       Date:  2019-07-31       Impact factor: 2.692

8.  The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

Authors:  Tinne Lernout; Benoît Kabamba-Mukadi; Veroniek Saegeman; Marie Tré-Hardy; Morgane de Laveleye; Tommi Asikainen; Ram Benny Dessau; Sophie Quoilin; Amber Litzroth
Journal:  BMC Public Health       Date:  2019-05-17       Impact factor: 3.295

9.  Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS).

Authors:  Manuel Dehnert; Volker Fingerle; Christiane Klier; Thomas Talaska; Martin Schlaud; Gérard Krause; Hendrik Wilking; Gabriele Poggensee
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Epidemiology of Lyme Disease in a Highly Endemic European Zone.

Authors:  Agnė Petrulionienė; Daiva Radzišauskienė; Arvydas Ambrozaitis; Saulius Čaplinskas; Algimantas Paulauskas; Algirdas Venalis
Journal:  Medicina (Kaunas)       Date:  2020-03-05       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.